×




Disrupting Dengue with an Emerging Markets Launch Strategy Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Disrupting Dengue with an Emerging Markets Launch Strategy case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Disrupting Dengue with an Emerging Markets Launch Strategy case study is a Harvard Business School (HBR) case study written by Stephen E. Chick, Ridhima Aggarwal. The Disrupting Dengue with an Emerging Markets Launch Strategy (referred as “Dengvaxia Dengue” from here on) case study provides evaluation & decision scenario in field of Leadership & Managing People. It also touches upon business topics such as - Value proposition, Emerging markets, Product development, Risk management.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Disrupting Dengue with an Emerging Markets Launch Strategy Case Study


Sanofi Pasteur's newly approved dengue vaccine, Dengvaxia, was unusual in that it was launched in the Philippines and other at-risk countries. By choosing to "flip the model" - launch in an emerging market setting as opposed to developed markets - it had to overcome various obstacles across the value chain, from registration to financing to supply. The company spent 20 years and invested $1.7 billion to develop Dengvaxia, taking several high-risk decisions and making trade-offs along the way. The case highlights the stakeholder interdependencies and uncertainties that remained as the vaccine implementation programme crept closer. If successfully resolved, it could potentially offer a blueprint for others.


Case Authors : Stephen E. Chick, Ridhima Aggarwal

Topic : Leadership & Managing People

Related Areas : Emerging markets, Product development, Risk management




Calculating Net Present Value (NPV) at 6% for Disrupting Dengue with an Emerging Markets Launch Strategy Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10023789) -10023789 - -
Year 1 3467699 -6556090 3467699 0.9434 3271414
Year 2 3960803 -2595287 7428502 0.89 3525101
Year 3 3967542 1372255 11396044 0.8396 3331225
Year 4 3242694 4614949 14638738 0.7921 2568517
TOTAL 14638738 12696257




The Net Present Value at 6% discount rate is 2672468

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Payback Period
2. Profitability Index
3. Net Present Value
4. Internal Rate of Return

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Dengvaxia Dengue have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Dengvaxia Dengue shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Disrupting Dengue with an Emerging Markets Launch Strategy

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Leadership & Managing People Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Dengvaxia Dengue often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Dengvaxia Dengue needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10023789) -10023789 - -
Year 1 3467699 -6556090 3467699 0.8696 3015390
Year 2 3960803 -2595287 7428502 0.7561 2994936
Year 3 3967542 1372255 11396044 0.6575 2608723
Year 4 3242694 4614949 14638738 0.5718 1854021
TOTAL 10473071


The Net NPV after 4 years is 449282

(10473071 - 10023789 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10023789) -10023789 - -
Year 1 3467699 -6556090 3467699 0.8333 2889749
Year 2 3960803 -2595287 7428502 0.6944 2750558
Year 3 3967542 1372255 11396044 0.5787 2296031
Year 4 3242694 4614949 14638738 0.4823 1563799
TOTAL 9500137


The Net NPV after 4 years is -523652

At 20% discount rate the NPV is negative (9500137 - 10023789 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Dengvaxia Dengue to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Dengvaxia Dengue has a NPV value higher than Zero then finance managers at Dengvaxia Dengue can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Dengvaxia Dengue, then the stock price of the Dengvaxia Dengue should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Dengvaxia Dengue should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What can impact the cash flow of the project.

Understanding of risks involved in the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Disrupting Dengue with an Emerging Markets Launch Strategy

References & Further Readings

Stephen E. Chick, Ridhima Aggarwal (2018), "Disrupting Dengue with an Emerging Markets Launch Strategy Harvard Business Review Case Study. Published by HBR Publications.


Kubota Pharma SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Sin Heng Heavy Machinery Ltd SWOT Analysis / TOWS Matrix

Capital Goods , Constr. & Agric. Machinery


YD More Invest SWOT Analysis / TOWS Matrix

Financial , Investment Services


P-Ban.Com SWOT Analysis / TOWS Matrix

Services , Retail (Catalog & Mail Order)


Quantrx Biomedical SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Cocolonet SWOT Analysis / TOWS Matrix

Services , Personal Services


Debflex SWOT Analysis / TOWS Matrix

Technology , Electronic Instr. & Controls


Byleasing SWOT Analysis / TOWS Matrix

Financial , Consumer Financial Services


China HGS RE SWOT Analysis / TOWS Matrix

Services , Real Estate Operations